Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Ovarian Neoplasms 26Uterine Cervical Neoplasms 16Endometrial Neoplasms 14Fallopian Tube Neoplasms 10Carcinoma, Ovarian Epithelial 7Colorectal Neoplasms 6Peritoneal Neoplasms 5Neoplasms 5Uterine Cervical Dysplasia 4Lung Neoplasms 4Gestational Trophoblastic Disease 4Pancreatic Neoplasms 3Neoplasms by Site 3Neoplasms by Histologic Type 3Melanoma 3Hematologic Neoplasms 3Endometrial Hyperplasia 3Urinary Bladder Neoplasms 2Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Stomach Neoplasms 2Prostatic Neoplasms 2Progesterone Resistance 2Ovarian Cysts 2Obesity 2Multiple Myeloma 2Lymphoproliferative Disorders 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Glioma 2

Interventions

Tablets 1Megestrol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Overweight × Gynecologic × Clear all
NCT05316467 2025-08-11

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Recruiting
89 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡